Literature DB >> 9180181

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey.

P W Hermans1, M Sluijter, K Elzenaar, A van Veen, J J Schonkeren, F M Nooren, W J van Leeuwen, A J de Neeling, B van Klingeren, H A Verbrugh, R de Groot.   

Abstract

The molecular epidemiologic characteristics of penicillin-resistant pneumococci in the Netherlands were investigated in 1995. Dutch electronic surveillance data showed that 0.7% of all pneumococci were intermediately resistant and 0.4% were highly resistant to penicillin. From March 1995 to March 1996, 89 penicillin-resistant isolates were collected by 39 medical microbiology laboratories. Thirty different genotypes were observed by restriction fragment end labeling. Twenty-one DNA types were unique, whereas 9 distinct genotypes were shared by > or = 2 isolates. Different serogroups were found within 6 of the 9 genetically identical clusters of penicillin-resistant isolates, suggesting that horizontal transfer of capsular genes is common. Finally, nosocomial transmission of penicillin-resistant pneumococci was observed among 21 elderly adults with chronic obstructive pulmonary disease. This study demonstrates that multiple clones of penicillin-resistant pneumococci have been introduced in the Netherlands, a country with a low prevalence of pneumococcal infection. Some clones spread among the population in and outside hospitals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180181     DOI: 10.1086/516474

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.

Authors:  K Overweg; A Kerr; M Sluijter; M H Jackson; T J Mitchell; A P de Jong; R de Groot; P W Hermans
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.

Authors:  K Overweg; D Bogaert; M Sluijter; J Yother; J Dankert; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Molecular epidemiology of penicillin-nonsusceptible Streptococcus pneumoniae among children in Greece.

Authors:  D Bogaert; G A Syrogiannopoulos; I N Grivea; R de Groot; N G Beratis; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

4.  Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years.

Authors:  R A Damoiseaux; F A van Balen; A W Hoes; T J Verheij; R A de Melker
Journal:  BMJ       Date:  2000-02-05

5.  Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes.

Authors:  I Vickers; D O'Flanagan; M Cafferkey; H Humphreys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-13       Impact factor: 3.267

6.  Molecular characterization of non-penicillin-susceptible Streptococcus pneumoniae in Norway.

Authors:  Maren K R Sogstad; E Arne Høiby; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 7.  Antigenic diversity and gene polymorphisms in Haemophilus influenzae.

Authors:  J R Gilsdorf
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 8.  Application of molecular typing to the epidemiology of Streptococcus pneumoniae.

Authors:  L M Hall
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

Review 9.  Community acquired infections and bacterial resistance.

Authors:  H Goossens; M J Sprenger
Journal:  BMJ       Date:  1998-09-05

10.  Molecular epidemiology of penicillin-susceptible, multidrug-resistant serotype 6B pneumococci isolated from children in Greece.

Authors:  G A Syrogiannopoulos; D Bogaert; I N Grivea; N G Beratis; R De Groot R; P W Hermans
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.